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Immune cells respond to chemotactic signals by means of G
protein-coupled receptors. Attempts to elucidate the function of
specific G protein family members in these responses is compli-
cated by redundancy among the different G protein isoforms. We
have used lentiviral-based RNA interference to eliminate expres-
sion of specific G protein subunits selectively in J774A.1 mouse
macrophages. The chemotactic response to the complement fac-
tors C5a and C3a is ablated in cells lacking G2 but is unaffected in
cells lacking G1, Gi2, or Gi3. Similarly, the C5a-mediated calcium
response of single cells is either absent or significantly delayed and
weakened by G2 knockdown. Assessment of Akt1 phosphoryla-
tion levels in response to C5a shows rapid and sustained phos-
phorylation in both wild-type cells and cells lacking G1. Cells
lacking G2 retain the rapid response but cannot sustain phospho-
Akt1 levels. The phenotype of cells lacking G2 can be reversed by
overexpression of either human G2 or mouse G1. These data
demonstrate the usefulness of lentiviral-based RNA interference in
the systematic analysis of a signaling pathway, and they suggest
that in J774A.1 cells, G2-derived G is the most effective medi-
ator of chemotaxis to C5a.
The specificity of G protein-coupled receptors derives bothfrom ligand binding and from the activation of intracellular
signaling pathways. Biochemical and molecular genetic ap-
proaches have been used to map the intracellular interactions
that underlie information processing. This task is complex
because it involves resolving interactions among homologous
components with similar biochemical activity. Thus, for example,
G protein-coupled receptors that control chemotaxis in immune
cells (e.g., chemokine or C5a receptors), when activated by
specific ligand binding at the cell surface, catalyze the disasso-
ciation of the intracellular heterotrimeric G proteins, releasing
the GTP-bound Gi subunit and the cognate G dimer (1–3).
The free  dimer is required for the initiation of cellular
chemotaxis because treatment of the cells with pertussis toxin
(PTx), which interferes specifically with the disassociation of
G from members of the Gi family, inhibits chemotaxis (4, 5).
There may be some residual role also for the Gi subunit (5).
Although the inhibitor studies provide some clarity, they do not
distinguish readily between the Gi or  homologs. There are
3 genes that encode different Gi subunits, 5 genes that encode
 subunits, and 12 genes that encode  subunits (6). Only subsets
of these genes are expressed in immune cells; however, it is
difficult to determine the precise roles of the isoforms that are
expressed because they have very similar biochemical activity
(7). With respect to chemotaxis, G has been shown to interact
with and to activate a variety of proteins, including phospho-
lipase C (PLC)-2, PLC-3, PLC-, p21-activated kinase 1,
phosphatidylinositol 3-kinase, and isoforms of adenylyl cyclase
(8–11). In addition,  has been shown to modulate the activity
of a various ion channels (12, 13). There is evidence that, in some
contexts, different  combinations may show specificity with
respect to the effectors with which they interact (14). However,
 dimers of different composition have also been found to
replace each other equally well in other circumstances (15).
It has been difficult to apply genetic techniques to the question
of specific isoform function in mammalian cells. However, the
recent development of gene silencing with double-stranded small
interfering RNA (siRNA) potentially may provide the level of
resolution that is necessary to eliminate specific isoforms so that
the effects of their loss on cellular function can be observed (16,
17). siRNA sequences have been shown to ablate gene activity
in a sequence-specific fashion (18). Furthermore, lentiviral
vectors have been shown to act as an efficient means for
generating siRNA complexes (19). By inserting into the cellular
genome, they can be used to generate cell lines that express a
specific siRNA as a hairpin structure, which is processed sub-
sequently into siRNA. The lentiviral vectors can be used for
extensive studies in tissue culture. In addition, these constructs
infect stem cells, and they can be transplanted into irradiated
hosts to reconstitute the immune system for physiological studies
(20). In this article, we demonstrate the systematic application of
gene elimination by siRNA to the analysis of the function of
individual components of a G protein-coupled receptor signaling
pathway. We used the analysis of the C5a-mediated signaling in
the J774A.1 macrophage cell line as a model system to explore
this approach.
Materials and Methods
Vector Construction. A mouse H1 RNA polymerase III promoter
was amplified from mouse genomic DNA and cloned at EcoRI–
BamHI sites of pBS-SKII plasmid, which was obtained from
Stratagene (21). To construct the 19–21 nucleotide hairpin
siRNA cassettes, two complementary DNA oligonucleotides
were chemically synthesized, annealed, and inserted between the
BamHI and XhoI sites immediately downstream of the H1
promoter: 5-GATCCCC19–21TTCAAGAGA19–21TTTTTC-3
and 3-GGG19–21AAGTTCTCT19–21AAAAAGAGCT-5. We
picked more than four siRNA target sequences for each gene
and tested the expression efficiency by cotransfecting into hu-
man embryonic kidney (HEK)-293 cells with a GFP gene-fusion
target gene. After expression for 48 h, the levels of residual GFP
fusion proteins were assessed by Western blotting with anti-GFP
serum (Santa Cruz Biotechnology). The target sequences for
each of the genes were as follows: G1, 5-CATTATCTGTG-
GTATCACATC-3, corresponding to nucleotide positions 804–
824; G2, 5-CATCTGCTCCATCTATAGTC-3, correspond-
ing to positions 357–376; G4, 5-CATCTGCTCCATATACAAC-
3, corresponding to positions 357–375; Gi2, 5-GCAC-
AGAGTGACTACATCC-3, corresponding to positions 490–508;
and Gi3, 5-GGAGTGCTGAAGAAGGAGT-3, corresponding
to positions 335–353.
The lentiviral vector pL-UGIP was derived from FG12 (22).
Abbreviations: HEK, human embryonic kidney; PLC, phospholipase C; siRNA, small inter-
fering RNA; UbiC, ubiquitin C; PTx, pertussis toxin; [Ca2]i, intracellular Ca2 concentration;
ERK, extracellular signal-regulated kinase.
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Internal ribosome entry site and puromycin-resistance gene
sequences were inserted downstream of the GFP gene. The
expression of both of the genes was driven by the ubiquitin C
(UbiC) promoter. To construct the siRNA-expressing lentiviral
vectors, the siRNA cassette containing H1 promoter and hairpin
sequences was subcloned into the XbaI and XhoI sites upstream
of the UbiC promoter (Fig. 1A). The cDNAs corresponding to
the G subunits were obtained by PCR from a mouse brain
cDNA library and cloned into the SalI and BamHI sites of
pEGFP-C1 (Clontech).
Human cDNA of G2 was isolated from HEK-293 cells by
RT-PCR. We used a modified form of pMIG that contained
woodchuck hepatitis B virus RNA regulatory element (WRE)
sequences to generate constructs of the full-length human G2
or mouse G1 cDNA in a retroviral vector containing a GFP
gene as a marker (23). The retroviruses were generated in
HEK-293T cells cotransfected with the expression vector
pMIGW-hG2 and the accessory vector pCMVgag-pol (Fig.
1B). All resulting plasmids were confirmed by restriction enzyme
analysis and DNA sequencing.
Lentivirus Generation. Lentivirus production was done as de-
scribed (22). Briefly, HEK-293T cells were cotransfected with
appropriate amounts of vector plasmid, the HIV-1 lentiviral
packaging constructs pRSVEV and pMDLgpRRE (24), and
the VSV-G expression plasmid pHCMVG (25) by using the
calcium phosphate transfection method. The viruses were col-
lected from the culture supernatants after 28 h and concentrated
100-fold by ultracentrifugation (25). The concentrated virus
stocks were titered on HEK-293 cells based on GFP expression.
Titers for the siRNA expression constructs were 5  108
plaque-forming units per ml.
Cell Culture and Lentivirus Transduction. J774A.1 cells (obtained
from the American Type Culture Collection) were maintained in
DMEM containing 10% FCS, 100 unitsml penicillin, and 100
gml streptomycin. The cells were transduced with concen-
trated virus at a multiplicity of infection of 10–20 in the presence
of 8 gml Polybrene (Sigma). Supernatant was removed after
8 h and replaced with growth medium. Cells were incubated 4
days after infection with 2 gml puromycin for 1 day to select
infected cells. GFP expression in selected cells was confirmed by
fluorescence-activated cell sorting.
Western Blotting. All cells were lysed with radioimmunoprecipi-
tation assay buffer (150 mM NaCl50 mM NaF20 mM Tris, pH
7.51% Triton X-1000.5% sodium deoxycholate), supple-
mented with complete protease inhibitor tablets (Roche Diag-
nostics). Protein concentration was measured by using protein
assay buffer (Bio-Rad). Equal amounts of protein (30 g) were
loaded per lane and separated on an SDS4–20% PAGE gel
(Invitrogen). Protein was transferred to a nitrocellulose mem-
brane and incubated with specific antibody at the appropriate
concentration and goat anti-rabbit or anti-mouse antibody con-
jugated with horseradish peroxidase (1:5,000). Anti-Gi2 anti-
body was provided by Susanne Mumby (University of Texas
Southwestern Medical Center, Dallas). Phospho-specific anti-
bodies were purchased from Cell Signaling Technology (Beverly,
MA), and the other antibodies were purchased from Santa Cruz
Biotechnology. The blot was developed with enhanced chemi-
luminescence reagent (Amersham Biosciences).
Chemotaxis. J774A.1 cells were eluted with PBS containing 2 mM
EDTA, washed twice, and suspended at a concentration of 1 
106 cells per ml in migration assay buffer (DMEM containing 2
mgml BSA). Migration was measured by using 96-well chemo-
taxis chambers (Neuroprobe, Cabin John, MD) with polycar-
bonate filter (5 m pore size). The lower wells were filled with
29 l of assay buffer containing various concentrations of
chemoattractants. After addition of 25 l of cell suspension to
the upper part of each well, the chamber was incubated at 37°C
for 2 h. The filter was removed from between the chambers, and
cells adhering to upper surface were washed off with PBS and
stained with Diff-Quick (Baxter Diagnostics, McGaw Park, IL).
Migrated cells were counted at five randomly selected fields
under a microscope (1,000 magnification). All experiments
were performed in duplicated wells.
RT-PCR and Quantitative RT-PCR. Total RNA was prepared from
J774A.1 by using TRIzol (Invitrogen). cDNA library was syn-
thesized with SuperScript II reverse transcriptase (Invitrogen)
and screened for the mRNA of each G protein by PCR with
specific primers that covered the ORF. Then, PCR products
were subcloned into pBluescript SK vector and confirmed by
sequencing.
mRNA expression levels of each gene were quantitated by
TaqMan real-time RT-PCR (Applied Biosystems, Foster City,
CA) using gene-specific primers and normalized with GAPDH
mRNA. The primers of genes are as follows: G1, 5-TGGACAC-
GACAACCGAGTCA-3 (sense) and 5-GCCATGCCATCAT-
CAGTCAC-3 (antisense); G2, 5-GGATTCCATGTGCCGA-
CAG-3 (sense) and 5-GCATTGATGTCCGACTCGTG-3
(antisense); Gi2, 5-TGCCGTGGTCTACAGCAACA-3 (sense)
and 5-CGCTTCACGATGGCCAGTATA-3 (antisense); Gi3,
5-TGGCTCTCAGTGATTACGACCTT-3 (sense) and
5-GGTTCATTTCCTCATCCTCAGC-3 (antisense); G2, 5-
CTGGTAGAACAGCTGAAGATGGAA-3 (sense) and 5-GG-
ACACCTTTATCCTGTCGATGT-3 (antisense); G5, 5-CA-
TGACCCTCTGCTGACTGGA-3 (sense) and 5-GGGTCT-
GAAGGGATTCGTACTTG-3 (antisense); and GAPDH, 5-
AGTATGACTCCACTCACGGCAA-3 (sense) and 5-CCAT-
TCTCGGCCTTGACTGT-3 (antisense).
Measurement of Intracellular Ca2 Concentration ([Ca2]i). Cells were
grown in glass-bottom dishes (MatTek, Ashland, MA) and
loaded with fura 2 acetoxymethyl ester (2 M; Molecular
Probes) in assay buffer (Hanks’ balanced salt solution10 mM
Hepes, pH 7.2) for 30 min at room temperature. After washing,
the dish was placed on the stage of an IX71 inverted fluorescence
microscope (Olympus, Melville, NY) to which a digital imaging
system with electronically controlled excitation filter positions
and an associated software system (SLIDEBOOK, Version 4.0;
Intelligent Imaging Innovations, Denver) was attached. Mea-
surements of [Ca2]i were performed on individual cells at
Fig. 1. Construction of virus-based vectors. (A) Schematic diagram of the
siRNA-expressing lentiviral vector pL-UGIP. The hairpin form of siRNA is ex-
pressed under the control of a mouse H1RNA polymerase III promoter. The
vector also contains the enhanced GFP marker gene and the puromycin-
resistance gene (Puro) regulated by a UbiC promoter and separated by an
internal ribosome entry site (IRES) sequence. (B) Schematic diagram of G
subunit expressing the retroviral vector pMIGW. Expression of the G cDNA
and the enhanced GFP gene is controlled by an LTR region having promoter
activity. FLAP, HIV-1 FLAP element; WRE, woodchuck hepatitis B virus RNA
regulatory element.








excitation wavelengths of 340 and 380 nm and an emission
wavelength of 510 nm at 1.5-s intervals.
Results
Suppression of G Proteins by Subtype-Specific siRNAs. The mouse
macrophage cell line J774A.1 contained mRNA corresponding
to the G1, G2, and G5 genes and had low levels of mRNA for
G4; G3 was not detected. Specific transcripts were detected
also for the Gi subunits, with relatively low levels for Gi1 (Fig.
2A). Proteins corresponding to G4, G5, or Gi1 were not
observed in Western blotting with isotype-specific antibodies
(data not shown), suggesting that the expression of these proteins
was absent or too low to be detected.
To obtain an effective siRNA sequence, we synthesized more
than four different siRNA hairpins specific for mRNA corre-
sponding to each mouse G protein subunit. Initial experiments
were performed in HEK-293 cells to test the efficiency of
inhibition of expression elicited after transfecting the cells with
plasmids expressing GFP-tagged forms of the G protein subunit.
We chose the siRNA that showed 95% inhibition of the
expression of the target proteins. Then, the specificity of inhi-
bition of the target gene was examined by cotransfecting siRNA
constructs with constructs expressing each isotype of the G
protein subunit. The target protein of each siRNA almost
disappeared, whereas the expression of the other isotypes was
unchanged (Fig. 2 B and C).
Suppression of Endogenous G Proteins by Lentivirus Carrying siRNA.
Electroporation or lipid-mediated transfection methods devel-
oped to date give low gene delivery in several types of cells,
including J774A.1. To increase the efficiency, we used lentivirus-
mediated gene transfer (22). The lentiviral vector expresses a
human UbiC-driven GFP gene and a puromycin-resistance gene,
which provide a visual marker and a selection for tracking or
enriching for transduced cells, respectively (Fig. 1 A). After virus
infection and selection with puromycin, 98% of the cells
showed a GFP-positive signal when tested by fluorescence-
activated cell sorter analysis. To confirm the specific gene
silencing effect of siRNA in the J774A.1 cells, we used quanti-
tative RT-PCR with specific primers and immunoblotting
against endogenous proteins with isotype-specific antibodies.
The relative mRNA level, normalized with GAPDH mRNA, was
decreased by 90% in cells transduced by virus carrying each
isotype-specific siRNA (Fig. 3 A and C). Consistent with quan-
titative RT-PCR data, significant down-regulation of target gene
expression was observed by Western blot analysis, whereas
expression of the other isotypes was not affected by the siRNA
(Fig. 3 B and C).
The Cells Lacking G2 Did Not Migrate to Chemotactic Factors. To
study the biological relevance of the suppression of endogenous
G protein expression by siRNA, we investigated cellular re-
sponses to extracellular stimulation. J774A.1 cells are known to
express classical types of the C5a and C3a chemokine receptors
(26). By using chemotaxis assays to various chemokines, we also
found activity corresponding to the CXCR4 and the SDF1
receptor; expression levels, however, were very low (data not
shown). In the present study, we used C5a and C3a as agonists.
As shown in Fig. 4 A and B, J774A.1 cells migrated across
polycarbonate filters toward a source of chemokines. The con-
centration–response curves were bell-shaped, peaking at 1–10
Fig. 2. Expression of G protein mRNAs in J774A.1 and silencing of G proteins
by subtype-specific siRNAs. (A) RT-PCR was performed by using total RNA
isolated from J774A.1. After PCR (30 cycles) with subtype-specific primers,
one-fifth of the product was loaded on a 1% agarose gel. For controls (C),
cDNA corresponding to the G or G subunit was used. Alternatively, the RT
product derived from the J774A.1 cells (J) was used. SM, size markers. (B and
C) siRNA constructs contained in pSK vectors were transfected into HEK-293
cells with plasmid, maintaining the cDNA corresponding to the enhanced GFP
fusion form of each G protein. After 48 h, Western blotting was performed
with an anti-GFP antibody.
Fig. 3. siRNA-mediated inhibition of endogenous G protein expression. (A
and C) After puromycin selection, mRNA levels of G proteins in lentivirus-
transduced cells were analyzed by TaqMan RT-PCR. The mRNA level of each G
protein was reduced specifically in the cells containing its siRNA. mRNA levels
were normalized to GAPDH mRNA. (B and D) Western blotting using subtype-
specific antibodies. G proteins were significantly down-regulated in the cells
containing the corresponding siRNA. Protein expression was normalized to
tubulin levels in total cell extracts.
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nM for the C5a ligand and at 0.6–2.5 nM for the C3a ligand.
Pretreatment of cells with PTx (100 ngml) for 12 h completely
inhibited the ability of the cells to generate chemotactic re-
sponses to C5a and C3a (Fig. 4 A and B), consistent with previous
results, which suggested that Gi subfamily-mediated signaling
pathways were involved in cell migration in the chemoattractant
gradient (27, 28). Given this result, we examined migration of the
cells containing siRNA directed against Gi2 or Gi3. The
migration-response curves of these cells were similar to those of
wild-type or empty virus-transduced cells, suggesting that the
presence of only one subtype of Gi family protein expressed in
the cell was sufficient to compensate for the absence of the other
subtype. The cells containing G2 siRNA did not migrate toward
C5a and C3a, whereas the cells containing G1 and G4 siRNA
showed migration efficiency similar to that of control cells. Loss
of chemotaxis in the cells treated with G2 siRNA was similar
to the effect of PTx and was not compensated by the endogenous
residual G subtypes.
G2 siRNA Inhibited [Ca2]i Transients Induced by C5a. G subunits
released from the GTP-bound form of Gi increase cytoplasmic
Ca2 concentration by activating PLC- (29, 30). Therefore, we
measured cytoplasmic Ca2 increase in response to C5a stimu-
lation by using fluorescence microscopy. To determine the
source of Ca2 influx, C5a-induced [Ca2]i responses were
examined in the presence of Ca2-free assay buffer containing
200 M EGTA. In this condition, [Ca2]i responses were similar
to the responses obtained in calcium-containing buffer. Next, we
examined changes of [Ca2]i responses by inhibiting PLC activity
with U73122 and depleting internal calcium stores with thapsi-
gargin. When cells are pretreated with 10 M U73122 or 1 M
thapsigargin for 10 min, the responses to C5a were completely
inhibited (Fig. 4C). Treatment of control cells and G1 siRNA-
containing cells showed maximum Ca2 increase at 20 nM C5a
(Fig. 4D). PTx pretreatment completely inhibited the Ca2
increase, confirming that the Ca2 increase was derived from a
Gi-mediated pathway. The responses of G2 siRNA-containing
single cells to C5a were heterogeneous: approximately half of the
tested cells showed little or no response, and the remaining half
showed delayed weak response or a delayed weak biphasic
response. Some of the heterogeneity in the low responding cells
may result from residual levels of G2 protein. We used puro-
mycin selection, and the resulting population may include cells
with different numbers or positions of viral insertion leading to
variable degrees of G2 suppression. Consistent with previous
work, these data indicate that C5a stimulates calcium mobiliza-
tion from inositol trisphosphate-dependent internal calcium
stores and that G2 is involved in robust PLC- activation.
Expression of G Subunits Was Down-Regulated in the Cells Lacking
G2. Some protein interaction is necessary for the stability of the
members of signaling-protein complexes. Thus, for example,
ablation of G subunit expression destabilizes uncomplexed G
(31). Furthermore, RGS proteins containing the G protein
-like domain (RGS6, RGS7, RGS9, and RGS11) are G5
binding partners; they are destabilized and degraded in mice
lacking G5, and reciprocally, G5 protein is degraded in the
absence of a suitable interacting subunit (32, 33). To examine the
stability of G and G subunits as a function of G suppression,
we performed quantitative RT-PCR and Western blotting. The
steady-state mRNA levels corresponding to Gi2, Gi3, G2, and
G5 were not affected in the cells lacking G subunits, compared
with control cells (data not shown). Protein levels of Gi2 and
Gi3 were not changed significantly, whereas G2 was consid-
erably down-regulated in the cells lacking G2 but not G1 or
G4. G5 was down-regulated in the cells lacking G1 and was
not detected in the cells lacking G2 (Fig. 5A).
G subunits, especially G2, affected the stability of their G
subunit binding partners, suggesting that G2 may be the pri-
mary molecule binding to G2 and G5. There may be other 
subunits expressed as well; however, we were not able to obtain
reagents to test for the presence of all of the  subunits.
Expression of Exogenous G Subunits Restored Cellular Responses to
C5a. To examine the specificity of the response to the absence of
G2 further, we studied the effect of reexpression of G subunits
on cellular responses. We generated retroviruses (Fig. 1) ex-
pressing either human G2 or G1. Although the amino acid
sequences of the human and mouse G proteins are the same,
the nucleic acid sequences in third codon positions are different.
G2 siRNA target sequences corresponding to the mouse gene
were coincident with that of the human gene except for two
nucleotides. Mouse G2 siRNA did not block expression of
human G2 (Fig. 5B). Exogenous expression of human G2
restored expression of G2 and G5. However, G subunits were
restored also by overexpression of G1 in the absence of G2
Fig. 4. Effects of G protein silencing on cellular responses to chemokines. (A and B) Chemotaxis in J774A.1 cells toward C5a (A) and C3a (B). Chemotaxis was
analyzed by using transwell migration, as described in Materials and Methods. Cells expressing siRNA corresponding to each G protein were incubated with or
without 100 ngml PTx for 12 h before the chemotaxis assays. The data are expressed as the mean  SE of three independent experiments. F, pL-UGIP (cells
infected with lentivirus lacking insert, see Fig. 1); E, PTx-treated pL-UGIP; Œ, G1 siRNA; , G2 siRNA; , G4 siRNA;, Gi2 siRNA; ‚, Gi3 siRNA. (C) C5a-induced
calcium transient was PLC--dependent. Cells loaded with fura 2 acetoxymethyl ester were stimulated with C5a, and changes in fluorescence in single cells were
monitored. Similar traces were obtained in 20 recordings of different cells. U73122 (‚), a PLC inhibitor, or thapsigargin (), an endoplasmic reticular Ca2-ATPase
inhibitor, blocked C5a-induced [Ca2]i increase. After a 10-min treatment with 10M U73122 or 1M thapsigargin, C5a was added. C5a-induced [Ca2]i increase
was unchanged in calcium-free buffer containing 200M EGTA (E).F, No pretreatment. (D) Inhibition of [Ca2]i increase by C5a in the cells containing G2 siRNA.
In control cells and G1 siRNA-containing cells, C5a induced [Ca2]i increases, which were blocked by PTx pretreatment for 12 h. In contrast, G2 siRNA-containing
cells showed no or delayed calcium responses to C5a. The arrow indicates C5a time of addition.F, pL-UGIP;E, PTx-treated pL-UGIP;, G1 siRNA;, G2 siRNA
(no response); , G2 siRNA (delayed weak response);, G2 siRNA (delayed weak biphasic response).








(Fig. 5B). Moreover, in G2 siRNA-containing cells transduced
with retroviruses carrying either the human G2 or G1 gene,
chemotactic efficiency was similar to that of wild-type cells (Fig.
5C). This result suggests that overproduction of G1 can com-
pensate for the decreased level of G2. These data are consistent
with results that showed no difference in activity between G1
and G2 in in vitro experiments and with overexpression exper-
iments used to define the roles of each of the G subunits
(34, 35).
G2 siRNA Treatment Modified the Kinetics of Akt Phosphorylation.
Phosphatidylinositol 3-kinase  (PI3K) plays a major role in cell
migration toward chemokines by interacting with G subunits
(9, 36). To follow PI3K activity, we examined Akt phosphor-
ylation, an event reflective of PI3K activation. On stimulation
with C5a, the Akt phosphorylation level on Ser-473 was in-
creased at 2 min and sustained for 30 min in control cells. This
sustained phosphorylation was found also in cells containing
G1 siRNA. In G2 siRNA-containing cells, phosphorylation
occurred at 2 min but vanished by 15 min, implying that
interaction of G2 with a downstream element (possibly PI3K)
extended Akt phosphorylation (Fig. 6A). Exogenous expression
of human G2 or G1 in G2 siRNA-containing cells restored
prolonged phosphorylation to the level seen in control cells,
consistent with the restoration of migration efficiency observed
in these cells. In contrast to Akt phosphorylation, ERK phos-
phorylation after C5a addition did not change in cells lacking
G2, compared with control cells and G1 siRNA-containing
cells (Fig. 6B). Thus, in contrast to Akt phosphorylation, the
signaling pathways for ERK phosphorylation were not affected
by the lack of one of the G subunits.
Discussion
RNA interference delivered by lentiviral vectors was used to
probe the relative contribution of components of the C5a
receptor-mediated chemotaxis pathway in the J774A.1 macro-
phage cell line. Cells were infected with virus carrying a variety
of different hairpin sequences that were processed into double-
stranded RNA, ablating target transcripts and blocking specific
protein expression. We found that the loss of either of the two
major members of the Gi family of G subunits in these cells,
Gi2 or Gi3, had little or no effect on chemotaxis. Furthermore,
the absence of the G1 subunit also did not affect chemotaxis.
However, the loss of the G2 subunit blocked chemotaxis
completely. The interpretation of these data is complicated
because the presence of the G subunit depends on the stability
of the G subunit, thus its expression is affected also by specific
G RNA interference. Much of the evidence suggests that G
and G act together in the dimer (37) to activate downstream
effectors and that the function of the G subunit is integral to
the activity of the G subunit. Furthermore, both G1 and G2
can bind various G subunits. Biochemical studies (38, 39)
suggest also that different G subunit combinations may have
very similar functions. It was surprising, therefore, that we saw
specificity for the loss of the G2 subunit. To determine whether
this specificity resided in the sequence of the G2 subunit or in
the level of G subunit, we replaced the mouse G subunits with
their human G subunit counterparts, which have the same
amino acid sequence but different transcripts, so that the human
protein could be expressed in the presence of mouse specific
siRNA. We found that replacement of mouse G2 by human G2
or by overexpression of G1 restored chemotaxis, suggesting that
a critical level of G subunit is required but that either G1 or
G2 could fulfill the downstream functions required for chemo-
taxis. One model would suggest that the kinetics of accumulation
of free  and its localization in the cell is critical to its signaling
function. Free  accumulation depends on many factors. These
factors include the catalytic activity of the receptor, the lifetime
of the cognate Gi–GTP complex, and the interaction of G
with various effectors and small molecules that can lead to its
Fig. 5. Changes in G protein expression by silencing or expression of G
cDNA. (A) Western blotting for Gi or G subunits. Protein levels of Gi2 and
Gi3 were not changed compared with control cells transfected with pL-UGIP
(empty viral vector). G2 expression was reduced significantly in G2-silenced
cells. G5 expression was reduced in G1-silenced cells and was not detected
in G2-silenced cells. (B) Western blotting for G and G subunits. G1 expres-
sion was enhanced by transduction of retrovirus carrying G1 gene (top blot,
lane four). G2 protein was detected in mouse G2-silenced cells transduced
with retrovirus carrying human G2 gene (second blot from the top, lane
three). Expressions of G2 and G5 were restored by exogenous expression of
human G2 or G1. (C) Expression of exogenous G subunits restored cellular
responses to C5a. Migration efficiency of G2-silenced cells was restored by
exogenous expressions of human G2 (Œ) or G1 (). The data are expressed
as the mean SE of three independent experiments.F, pL-UGIP;, G2 siRNA.
Fig. 6. C5a-stimulated phosphorylation of Akt and extracellular signal-regulated kinase (ERK). After incubation with media containing 1% FBS for 12 h, cells
were stimulated with C5a for the indicated times. Cell lysates were subjected to immunoblotting with specific antibodies against phosphorylated forms of Akt
(A) or ERK (B). The immunoblots were stripped and reprobed with anti-Akt or anti-ERK antibodies. (A) Akt phosphorylation by C5a was sustained 30 min in
control cells and G1-silenced cells, whereas phosphorylation was ended by 15 min after treatment in G2-silenced cells. Extended phosphorylation was restored
by expression of human G2 or G1. (B) In contrast to the results shown in A, C5a stimulated ERK phosphorylation by the same degree in control cells and
G-silenced cells.
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sequestration and translocation. Thus, although both 1 and 2
can function, a variety of kinetic factors could make the 2
dimers more effective sources for signal transmission. On the
other hand, G2 may have some specific affinity for a signaling
complex downstream of the C5a receptor. In its absence, en-
dogenous G1 is not able to function because it is sequestered.
However, exogenous overexpression of human G1 does com-
pensate. We were able to show in these experiments that at least
two downstream effectors were activated. One of these effectors
was PLC-, which leads to the rapid release of calcium, and the
other was the phosphorylation of Akt, which was extended and
stabilized by the presence of free G.
Although these initial experiments do not point unambigu-
ously to the downstream pathway that connects the release of
free  to the cytoskeletal changes that lead to chemotaxis, they
do demonstrate the usefulness of the application of siRNA. The
technique provides us with a precise tool to eliminate single
genes in a specific manner and to restore gene functions in these
backgrounds. The restored genes can be mutated to study their
specific activity in a background lacking the initial function.
Furthermore, it should be possible to apply double-stranded
RNA or antisense RNA directly to the lentiviral-infected cells to
generate a transient deficiency for two or three genes in a specific
pathway. Finally, these cells, with their lentiviral constructs,
provide a relatively stable platform that can be used for kinetic
studies of signaling pathways. Thus, we can generate models for
understanding the detailed functions of the signaling elements
and probe the quantitative relationships among these functions
in vivo.
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